Tirzepatide
Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that is being developed for the treatment of type 2 diabetes. Tirzepatide (LY3298176) shows significantly better efficacy with regard to glucose control and weight loss than do Dulaglutide.
Online Inquiry
| CAT# | R1721 |
| CAS | 2023788-19-2 |
| Synonyms/Alias | LY3298176 |
| M.F/Formula | C225H348N48O68 |
| M.W/Mr. | 4813.45 |
| Sequence | One Letter Code: Y-Aib-EGTFTSDYSI-Aib-LDKIAQ-diacid-gamma-Glu-(AEEA)2-Lys-AFVQWLIAGGPSSGAPPPS-NH2
Three Letter Code: Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys-diacid-gamma-Glu-(AEEA)2-Lys-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 |
| Storage | Store at -20°C |
Solubility | Soluble in DMSO |
Shipping Condition | Shipped with blue ice |
Write a review
Ask a question
My Review for Tirzepatide
Required fields are marked with *
×
Ask a Question for Tirzepatide
Required fields are marked with *
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
